Whole Shine Medical Technology Co., Ltd. (SHE:002622)
China · Delayed Price · Currency is CNY 2.440
-0.150 (-5.79%)
Sep 15, 2026, 3:04 PM CST
SHE:002622 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 2,176 | 2,495 | 2,318 | 2,747 | 3,108 | 3,696 | |
Market Cap Growth | -32.55% | 7.61% | -15.60% | -11.62% | -15.91% | 50.69% |
Enterprise Value | 2,526 | 2,886 | 2,706 | 3,092 | 3,491 | 3,845 |
Last Close Price | 2.59 | 2.97 | 2.76 | 3.27 | 3.70 | 4.40 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Forward PE | - | 17.26 | 17.26 | 17.26 | 17.26 | 17.26 |
PS Ratio | 3.09 | 3.55 | 2.69 | 3.63 | 6.21 | 21.99 |
PB Ratio | 7.01 | 8.01 | 5.23 | 5.91 | 5.47 | 4.21 |
P/TBV Ratio | 71.68 | 64.92 | 15.45 | 14.82 | 9.57 | 6.49 |
P/FCF Ratio | 26.08 | 56.55 | 29.51 | 26.57 | 376.39 | 292.62 |
P/OCF Ratio | 20.91 | 37.79 | 25.10 | 20.05 | 96.39 | 201.23 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.59 | 4.11 | 3.14 | 4.09 | 6.97 | 22.87 |
EV/EBITDA Ratio | 56.38 | - | 39.08 | 33.93 | - | 507.92 |
EV/EBIT Ratio | - | - | 52.43 | 42.11 | - | - |
EV/FCF Ratio | 30.28 | 65.42 | 34.45 | 29.90 | 422.81 | 304.41 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.42 | 1.45 | 1.08 | 1.08 | 0.89 | 0.65 |
Debt / EBITDA Ratio | 8.98 | 12.30 | 4.14 | 3.65 | - | 49.37 |
Debt / FCF Ratio | 5.27 | 10.21 | 6.07 | 4.84 | 61.27 | 45.44 |
Net Debt / Equity Ratio | 0.97 | 1.01 | 0.74 | 0.76 | 0.67 | 0.43 |
Net Debt / EBITDA Ratio | 10.59 | -170.72 | 4.76 | 3.87 | -7.56 | 50.40 |
Net Debt / FCF Ratio | 3.61 | 7.12 | 4.19 | 3.41 | 46.31 | 30.21 |
Asset Turnover | 0.51 | 0.49 | 0.57 | 0.48 | 0.29 | 0.11 |
Inventory Turnover | 7.48 | 8.45 | 7.89 | 6.41 | 5.60 | 2.17 |
Quick Ratio | 0.23 | 0.23 | 0.27 | 0.25 | 0.26 | 0.60 |
Current Ratio | 0.29 | 0.29 | 0.33 | 0.34 | 0.36 | 0.71 |
Return on Equity (ROE) | -28.00% | -34.43% | -3.36% | -11.27% | -38.72% | -8.44% |
Return on Assets (ROA) | 0.52% | -0.81% | 2.13% | 2.89% | -2.54% | -0.18% |
Return on Invested Capital (ROIC) | 1.86% | -2.63% | 6.49% | 8.30% | -6.30% | -0.38% |
Return on Capital Employed (ROCE) | 2.60% | -4.10% | 8.50% | 11.40% | -8.90% | -0.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | -5.04% | -4.79% | -1.63% | -3.44% | -8.26% | -2.06% |
FCF Yield | 3.83% | 1.77% | 3.39% | 3.76% | 0.27% | 0.34% |
Buyback Yield / Dilution | 2.73% | -0.04% | 0.10% | -0.03% | 0.50% | -0.50% |